Dr. Nizet is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Division of Host-Microbe Systems & Therapeutics
9500 Gilman Drive, Mail Code 0760
La Jolla, CA 92093Phone+1 858-537-7408
Summary
- Victor Nizet is a Distinguished Professor and Vice Chair for Basic Research and Chief of the Division of Host-Microbe Systems & Therapeutics at the University of California, San Diego (UCSD), School of Medicine as well as Distinguished Professor at UCSD Skaggs School of Pharmacy & Pharmaceutical Sciences. Dr. Nizet is a graduate of Reed College, received his medical training at Stanford University School of Medicine, completed a Residency and Chief Residency in Pediatrics at Harvard University's Children's Hospital in Boston, Massachusetts, and a then a Fellowship in Pediatric Infectious Diseases at the University of Washington’s Children's Hospital in Seattle.
Dr. Nizet leads a large basic and translational research laboratory studying microbial pathogenesis, innate immunity, and novel approaches to infectious disease therapy. He also spearheads the initiative for the UCSD Collaborative to Halt Antibiotic-Resistant Microbes (CHARM). Dr. Nizet has authored over 440 peer-reviewed publications and collaborated biopharma in developing new antibiotic and immune-based therapies against drug-resistant pathogens.
Dr. Nizet's work has been recognized by an American Heart Association Established Investigator Award, the American Lung Association Career Investigator Award, the American Asthma Foundation Senior Investigator Award, the E. Mead Johnson Award for Research in Pediatrics, and NIH Merit Award, and the 2016-17 UCSD Chancellor’s Associates Award for Faculty Excellence in Research in Science and Engineering. Dr. Nizet has been elected to the American Society for Clinical Investigation, the Association of American Physicians, and the American Academy of Microbiology. Details of his research program can be found on the laboratory website: http://nizetlab.ucsd.edu
Education & Training
- University of WashingtonFellowship, Pediatric Infectious Diseases, 1993 - 1996
- Boston Children’s Hospital/Boston Medical CenterChief Residency, Pediatrics, 1992 - 1993
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1989 - 1992
- Stanford University School of MedicineClass of 1989
Certifications & Licensure
- CA State Medical License 1997 - 2012
Awards, Honors, & Recognition
- Fellow American Academy of Microbiology, 2012
- Elected Member Association of American Physicians, 2010
- E. Mead Johnson Award for Research in Pediatrics Society for Pediatric Research, 2008
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsNeutrophil Extracellular Traps: An Emerging Therapeutic Target to Improve Infectious Disease Outcomes.Angela Meier, George Sakoulas, Victor Nizet, Erlinda R Ulloa
The Journal of Infectious Diseases. 2024-08-16 - 1 citationsAn efficient-inducible CRISPR interference system for group Agenetic analysis and pathogenesis studies.Elisabet Bjånes, Alexandra Stream, Axel B Janssen, Paddy S Gibson, Afonso M Bravo
Mbio. 2024-08-14 - PI3Kγ inhibition circumvents inflammation and vascular leak in SARS-CoV-2 and other infections.Ryan M Shepard, Anghesom Ghebremedhin, Isaraphorn Pratumchai, Sally R Robinson, Courtney Betts
Science Translational Medicine. 2024-07-03
Journal Articles
- Streptococcal Lancefield Polysaccharides Are Critical Cell Wall Determinants for Human Group IIA Secreted Phospholipase A2 to Exert Its Bactericidal EffectsVictor Nizet, MD, PLoS One
- Siglec-7 Engagement by GBS Β-protein Suppresses Pyroptotic Cell Death of Natural Killer CellsJack D Bui, Victor Nizet, Proceedings of the National Academy of Sciences
- Human Evolutionary Loss of Epithelial Neu5Gc Expression and Species-Specific Susceptibility to CholeraVictor Nizet, MD, PLoS One
- Join now to see all
Authored Content
- Machine Learning and Structural Analysis of Mycobacterium Tuberculosis Pan-Genome Identifies Genetic Signatures of Antibiotic ResistanceOctober 2018
- Listeria Monocytogenes Endocarditis: Case Report, Review of the Literature, and Laboratory Evaluation of Potential Novel Antibiotic SynergiesJanuary 2018
Press Mentions
- How to Combat the Antibiotic Resistance CrisisMay 5th, 2023
- Largest Bacterium Ever Discovered Has an Unexpectedly Complex CellFebruary 23rd, 2022
- County, City Officials Work to Contain Shigella Outbreak Among Homeless ResidentsOctober 16th, 2021
- Join now to see all
External Links
- Lab Websitehttp://nizetlab.ucsd.edu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: